Not applicableEnded earlyNCT05926544What this trial is testingCOVID-19 Vaccine Hesitancy Counseling Intervention for PharmacistsWho this might be right forCOVID-19 University of North Carolina, Chapel Hill 16
Post-approval studies (Phase 4)UnknownNCT05075044What this trial is testingImmunogenicity and Safety of an Inactivated COVID-19 Vaccine in People Aged ≥18 Years With HIV InfectedWho this might be right forHIV InfectionsCOVID-19 China National Biotec Group Company Limited 400
Post-approval studies (Phase 4)Study completedNCT02584543What this trial is testingA Phase Ⅳ Clinical Trial of the Recombinant Hepatitis E Vaccine (Escherichia Coli)(Coadministration With Recombinant Hepatitis B Vaccine)Who this might be right forHepatitis EHepatitis B Xiamen Innovax Biotech Co., Ltd 602
Testing effectiveness (Phase 2)Study completedNCT00880698What this trial is testingSafety and Immune Response of a Rotavirus Vaccine in HIV-infected and Uninfected Children Born to HIV-infected MothersWho this might be right forHIV InfectionRotavirus Infection National Institute of Allergy and Infectious Diseases (NIAID) 202
Testing effectiveness (Phase 2)Active Not RecruitingNCT07128121What this trial is testingDescribe the Safety and Immunogenicity of Respiratory Syncytial Virus Vaccine IN006 in Healthy Participants Aged 60 Years and OlderWho this might be right forRespiratory Syncytial Virus (RSV) Infection Shenzhen Shenxin Biotechnology Co., Ltd 500
Testing effectiveness (Phase 2)Study completedNCT05727215What this trial is testingHeterologous Booster Study of COVID-19 Protein Subunit Recombinant Vaccine in Children 12-17 Years of AgeWho this might be right forCOVID-19 PT Bio Farma 150
Not applicableStudy completedNCT02027233What this trial is testingClinical Trial to Assess the Influenza Vaccination of the Hospitalized AdultsWho this might be right forSevere Acute Respiratory Infection Institut National de la Santé Et de la Recherche Médicale, France 6,173
Testing effectiveness (Phase 2)UnknownNCT05172193What this trial is testingSafety & Immunogenicity of Booster SARS-CoV-2 Vaccine (Vero Cell)Who this might be right forCOVID-19 PT. Kimia Farma (Persero) Tbk 600
Large-scale testing (Phase 3)Study completedNCT05372016What this trial is testingEvaluate the Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy FemalesWho this might be right forHPV InfectionsCervical CancerVulvar Cancer+12 more Shanghai Bovax Biotechnology Co., Ltd. 1,200
Early research (Phase 1)Study completedNCT00252148What this trial is testingSafety and Immunogenicity of a Modified Vaccinia Ankara (MVA) HIV Vaccine in HIV Uninfected AdultsWho this might be right forHIV Infection International AIDS Vaccine Initiative 48
Not applicableStudy completedNCT02948933What this trial is testingCohort Event Monitoring for Dengvaxia®, CYD-TDV Dengue VaccineWho this might be right forDengue FeverDengue Hemorrhagic Fever Sanofi Pasteur, a Sanofi Company 30,000
Early research (Phase 1)Study completedNCT02374385What this trial is testingPhase I Trial to Assess the Safety, Tolerability and Immunogenicity of a Ebola Virus VaccineWho this might be right forEbola Viruses Dalhousie University 40
Large-scale testing (Phase 3)Study completedNCT00605085What this trial is testingSafety and Tolerability of the Japanese Encephalitis Vaccine IC51Who this might be right forJapanese Encephalitis Valneva Austria GmbH 2,675
Not applicableUnknownNCT05429047What this trial is testingPriming of the NEonatal Immune System by Transfer of Maternal ImmunityWho this might be right forCOVID-19Maternal Vaccine ExposureRespiratory Infections in Children Hannover Medical School 560
Testing effectiveness (Phase 2)Study completedNCT00000815What this trial is testingA Phase II, Comparative Study of Seroconversion of Single-Dose and Two-Dose Measles Vaccination in HIV-Infected and HIV-Uninfected Children: A Multicenter Trial of the Pediatric AIDS Clinical Trials GroupWho this might be right forHIV InfectionsMeasles National Institute of Allergy and Infectious Diseases (NIAID) 270
Early research (Phase 1)Enrolling By InvitationNCT07330440What this trial is testingA Phase I Study to Evaluate the Safety, Tolerability, and Immunogenicity of an mRNA Vaccine Against Herpes Simplex Virus Type 2 (HSV-2) Post-VaccinationWho this might be right forGenital Herpes Changchun BCHT Biotechnology Co. 144
Early research (Phase 1)Study completedNCT00001055What this trial is testingA Phase I Safety and Immunogenicity Trial of Live Recombinant Canarypox ALVAC-HIV (vCP205) in HIV-1 Uninfected Adult VolunteersWho this might be right forHIV Infections National Institute of Allergy and Infectious Diseases (NIAID) 76
Early research (Phase 1)Study completedNCT03674125What this trial is testingEvaluation of Safety, Tolerability, and Immunogenicity Study of GLS-6150 in Healthy Volunteers and in Persons Previously Treated for Hepatitis C Virus InfectionWho this might be right forHCV Infection GeneOne Life Science, Inc. 32
Large-scale testing (Phase 3)Study completedNCT01983540What this trial is testingAntibody Persistence at Age 3.5 and 4.5 Years After Primary and Booster DTaP-IPV-Hep B-PRP~T or Infanrix Hexa VaccinationWho this might be right forDiphtheriaTetanusWhooping Cough+3 more Sanofi Pasteur, a Sanofi Company 558
Large-scale testing (Phase 3)WithdrawnNCT04683224What this trial is testingEvaluate the Safety, Immunogenicity, and Efficacy of UB-612 COVID-19 VaccineWho this might be right forCovid-19SARS-CoV-2Coronavirus Vaxxinity, Inc.